Literature DB >> 21506126

Phosphorylation of AKT/PKB by CK2 is necessary for the AKT-dependent up-regulation of β-catenin transcriptional activity.

Daniela P Ponce1, Jose L Maturana, Pablo Cabello, Roger Yefi, Ignacio Niechi, Eduardo Silva, Ricardo Armisen, Mario Galindo, Marcelo Antonelli, Julio C Tapia.   

Abstract

β-Catenin is a key protein in the canonical Wnt signaling pathway and in many cancers alterations in transcriptional activity of its components are observed. This pathway is up-regulated by the protein kinase CK2, but the underlying mechanism of this change is unknown. It has been demonstrated that CK2 hyperactivates AKT/PKB by phosphorylation at Ser129, and AKT phosphorylates β-catenin at Ser552, which in turn, promotes its nuclear localization and transcriptional activity. However, the consequences of CK2-dependent hyperactivation of AKT on β-catenin activity and cell viability have not been evaluated. We assessed this regulatory process by manipulating the activity of CK2 and AKT through overexpression of wild-type, constitutively active and dominant negative forms of these proteins as well as analyzing β-catenin-dependent transcriptional activity, survivin expression and viability in HEK-293T cells. We observed that CK2α overexpression up-regulated the β-catenin transcriptional activity, which correlated to an increased nuclear localization of β-catenin as well as survivin expression. Importantly, these effects were strongly reversed when an AKT-S129A mutant was co-expressed in the same cells, followed by a significant decrease in cell viability but no changes in β-catenin stability. Taken together, the data suggest that the CK2α-dependent up-regulation of β-catenin activity requires phosphorylation of AKT in human embryonic kidney cells.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21506126     DOI: 10.1002/jcp.22527

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  31 in total

1.  Casein kinase-2 mediates cell survival through phosphorylation and degradation of inositol hexakisphosphate kinase-2.

Authors:  Anutosh Chakraborty; J Kent Werner; Michael A Koldobskiy; Asif K Mustafa; Krishna R Juluri; Joseph Pietropaoli; Adele M Snowman; Solomon H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-24       Impact factor: 11.205

2.  Casein Kinase 2: a novel player in glioblastoma therapy and cancer stem cells.

Authors:  Maya Agarwal; Ryan T Nitta; Gordon Li
Journal:  J Mol Genet Med       Date:  2013-12-09

3.  CK2 functionally interacts with AKT/PKB to promote the β-catenin-dependent expression of survivin and enhance cell survival.

Authors:  Daniela P Ponce; Roger Yefi; Pablo Cabello; Jose L Maturana; Ignacio Niechi; Eduardo Silva; Mario Galindo; Marcelo Antonelli; Katherine Marcelain; Ricardo Armisen; Julio C Tapia
Journal:  Mol Cell Biochem       Date:  2011-07-07       Impact factor: 3.396

Review 4.  Protein kinase CK2 in breast cancer: the CK2β regulatory subunit takes center stage in epithelial plasticity.

Authors:  Odile Filhol; Sofia Giacosa; Yann Wallez; Claude Cochet
Journal:  Cell Mol Life Sci       Date:  2015-05-20       Impact factor: 9.261

5.  Potent and Selective CK2 Kinase Inhibitors with Effects on Wnt Pathway Signaling in Vivo.

Authors:  James E Dowling; Marat Alimzhanov; Larry Bao; Claudio Chuaqui; Christopher R Denz; Emma Jenkins; Nicholas A Larsen; Paul D Lyne; Timothy Pontz; Qing Ye; Geoff A Holdgate; Lindsay Snow; Nichole O'Connell; Andrew D Ferguson
Journal:  ACS Med Chem Lett       Date:  2016-01-20       Impact factor: 4.345

6.  Cell rounding in cultured human astrocytes and vascular endothelial cells upon inhibition of CK2 is mediated by actomyosin cytoskeleton alterations.

Authors:  A A Kramerov; K Ahmed; A V Ljubimov
Journal:  J Cell Biochem       Date:  2012-09       Impact factor: 4.429

7.  Protein kinase CK2 enables regulatory T cells to suppress excessive TH2 responses in vivo.

Authors:  Alexander Ulges; Matthias Klein; Sebastian Reuter; Bastian Gerlitzki; Markus Hoffmann; Nadine Grebe; Valérie Staudt; Natascha Stergiou; Toszka Bohn; Till-Julius Brühl; Sabine Muth; Hajime Yurugi; Krishnaraj Rajalingam; Iris Bellinghausen; Andrea Tuettenberg; Susanne Hahn; Sonja Reißig; Irma Haben; Frauke Zipp; Ari Waisman; Hans-Christian Probst; Andreas Beilhack; Thierry Buchou; Odile Filhol-Cochet; Brigitte Boldyreff; Minka Breloer; Helmut Jonuleit; Hansjörg Schild; Edgar Schmitt; Tobias Bopp
Journal:  Nat Immunol       Date:  2015-01-19       Impact factor: 25.606

Review 8.  Morphogens and hepatic stellate cell fate regulation in chronic liver disease.

Authors:  Hidekazu Tsukamoto; Nian-Ling Zhu; Jiaohong Wang; Kinji Asahina; Keigo Machida
Journal:  J Gastroenterol Hepatol       Date:  2012-03       Impact factor: 4.029

9.  Inhibition of hydrogen peroxide signaling by 4-hydroxynonenal due to differential regulation of Akt1 and Akt2 contributes to decreases in cell survival and proliferation in hepatocellular carcinoma cells.

Authors:  Colin T Shearn; Philip Reigan; Dennis R Petersen
Journal:  Free Radic Biol Med       Date:  2012-05-01       Impact factor: 7.376

10.  Cross-species proteomics reveals specific modulation of signaling in cancer and stromal cells by phosphoinositide 3-kinase (PI3K) inhibitors.

Authors:  Vinothini Rajeeve; Iolanda Vendrell; Edmund Wilkes; Neil Torbett; Pedro R Cutillas
Journal:  Mol Cell Proteomics       Date:  2014-03-19       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.